Ledger.Open graph →
SEC Form D · filed January 24, 2020

Can-Fite BioPharma Ltd

Offering
$2.4M
Sold
$2.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PETACH TIKVA, L3
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Pnina Fishman · Petach Tikva, L3Exec · DirectorGuy Regev · Petach Tikva, L3DirectorIlan Cohn · Petach Tikva, L3DirectorMotti Farbstein · Petach Tikva, L3Exec · DirectorAbraham Sartani · Petach Tikva, L3DirectorYaacov Goldman · Yokne'am Illit, L3DirectorIsrael Shamay · Petach Tikva, L3DirectorJanon Costly · Washington, Washington, D.C.DirectorTerry Ransford · Chicago, ILDirectorRay G. Quintana · SANTA FE, NMDirectorGolan Bitton · Petach Tikva, L3DirectorKevin J. Ritterman · Fargo, NDExec · DirectorBarbara M. Fisk · Madison, ALDirectorJames R. Hudson, Jr · Huntsville, ALDirectorTacey R. Viegas · Madison, ALExec · DirectorStephen E. Memishian · Palm Beach Gardens, FLDirectorMichael J. Mcvean · Dallas, TXDirectorSteven Eisner · San Francisco, CADirectorGolan Bitton · Petach Tikva, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗